logo

Axogen, Inc. (AXGN)



Trade AXGN now with
  Date
  Headline
7/10/2018 7:11:30 AM AxoGen Appoints Lisa Colleran To Board Of Directors
5/21/2018 7:03:19 AM AxoGen Elects Karen Zaderej As Chairman In Addition To Her Current Role As President And CEO
5/14/2018 7:12:25 AM AxoGen Announces Closing Of Public Offering Of 3.45 Mln Common Stock At $41/Shr
5/9/2018 7:21:48 AM AxoGen Announces Upsizing And Pricing Of Public Offering Of Common Stock
2/5/2018 7:26:02 AM William Blair Starts AxoGen, Inc. (AXGN) At Outperform
1/8/2018 7:15:17 AM AxoGen Sees Q4 Revenue To Be At Least $16.5 Mln, Up 45%
12/18/2017 5:22:25 AM Riding High: AxoGen
11/21/2017 6:46:12 AM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2018 Estimate To -0.31 From -0.22
11/21/2017 6:45:49 AM Wedbush Is Increasing AxoGen, Inc. (AXGN) 2018 Rev. Estimate To 83.6 M From 83.3 M
11/16/2017 8:42:49 AM AxoGen Announces Pricing Of Public Offering Of Common Stock At $21.00/shr
11/2/2017 12:25:08 PM Wedbush Is Raising AxoGen, Inc. (AXGN) FY17 Estimate To -0.35 From -0.42
11/2/2017 12:24:51 PM Wedbush Is Raising AxoGen, Inc. (AXGN) Q4 17 Estimate To -0.11 From -0.14
8/3/2017 1:02:45 PM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2018 Estimate To -0.22 From -0.21
8/3/2017 1:02:31 PM Wedbush Is Cutting AxoGen, Inc. (AXGN) 2017 Estimate To -0.42 From -0.41
8/3/2017 1:02:12 PM Wedbush Is Cutting AxoGen, Inc. (AXGN) Q3 17 Estimate To -0.10 From -0.09
5/19/2017 7:03:16 AM Wedbush Reiterates AxoGen, Inc. (AXGN) At Outperform With $17 Up From $14 Price Target
2/23/2017 6:42:57 AM Wedbush Is Raising AxoGen, Inc. (AXGN) 2017 Rev. Estimate To 57.9 M From 57.11 M